Although AFP (3), PIVKA2 (4), GP73 (5), and other proteins have been identified as biomarkers for liver cancer diagnosis and treatment, there is currently no reliable tumor marker for patients with AFP-negative HCC. The gene discussed is GOLM1; the disease is hepatocellular carcinoma.